1. Home
  2. RYAN vs IRTC Comparison

RYAN vs IRTC Comparison

Compare RYAN & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryan Specialty Holdings Inc.

RYAN

Ryan Specialty Holdings Inc.

HOLD

Current Price

$53.10

Market Cap

7.3B

Sector

Finance

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$174.99

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYAN
IRTC
Founded
2010
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
5.8B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
RYAN
IRTC
Price
$53.10
$174.99
Analyst Decision
Buy
Strong Buy
Analyst Count
16
14
Target Price
$66.79
$204.64
AVG Volume (30 Days)
1.4M
439.5K
Earning Date
10-30-2025
10-30-2025
Dividend Yield
0.89%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,905,944,000.00
$702,573,000.00
Revenue This Year
$27.79
$27.20
Revenue Next Year
$16.67
$16.89
P/E Ratio
N/A
N/A
Revenue Growth
24.99
25.45
52 Week Low
$50.08
$84.17
52 Week High
$77.16
$212.00

Technical Indicators

Market Signals
Indicator
RYAN
IRTC
Relative Strength Index (RSI) 41.17 49.28
Support Level $52.60 $166.49
Resistance Level $56.00 $172.65
Average True Range (ATR) 1.77 6.07
MACD -0.25 -0.66
Stochastic Oscillator 21.66 35.18

Price Performance

Historical Comparison
RYAN
IRTC

About RYAN Ryan Specialty Holdings Inc.

Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: